Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies

Name: Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies
Published: 2018
License: Public Domain

Amgen · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

acute-myeloid-leukemia multiple-myeloma

multiple myeloma, acute myeloid leukemia, non-hodgkins lymphoma, myelodysplastic syndrome, aml, mds, nhl, mm, myeloid cell leukemia 1 inhibitor, mcl1 inhibitor, mcl1, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies

Related documents